Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data
暂无分享,去创建一个
Arthur N. Mayeno | Brad Reisfeld | Raymond S. H. Yang | Michael A. Lyons | Raymond S.H. Yang | B. Reisfeld | A. N. Mayeno | M. Lyons
[1] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.
[2] J. Hadamard. Sur les problemes aux derive espartielles et leur signification physique , 1902 .
[3] Harvey J Clewell,et al. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling , 2007, Journal of Exposure Science and Environmental Epidemiology.
[4] R A Corley,et al. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[5] Bradley P. Carlin,et al. BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..
[6] Harvey J Clewell,et al. Use of a Physiologically Based Pharmacokinetic Model to Identify Exposures Consistent With Human Biomonitoring Data for Chloroform , 2006, Journal of toxicology and environmental health. Part A.
[7] A. Gelman,et al. Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .
[8] Harvey J Clewell,et al. Use of Markov Chain Monte Carlo Analysis with a Physiologically‐Based Pharmacokinetic Model of Methylmercury to Estimate Exposures in U.S. Women of Childbearing Age , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[9] D B Rubin,et al. Markov chain Monte Carlo methods in biostatistics , 1996, Statistical methods in medical research.
[10] John K Kruschke,et al. Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.
[11] M. Sohn,et al. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study , 2004, Journal of Exposure Analysis and Environmental Epidemiology.
[12] L. Wallace. Human Exposure and Body Burden for Chloroform and Other Trihalomethanes , 1997 .
[13] K. Maurer,et al. Third national health and nutrition examination survey , 1985 .
[14] Don R. Maszle,et al. MCSim: A Monte Carlo Simulation Program , 1997 .
[15] Ken Sexton,et al. Human Biomonitoring of Environmental Chemicals , 2004 .
[16] I J Smeenk,et al. Drinking water contaminants. , 1983, Environmental science & technology.
[17] Harvey J Clewell,et al. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. , 2006, Regulatory toxicology and pharmacology : RTP.
[18] G Miller,et al. Bayesian internal dosimetry calculations using Markov Chain Monte Carlo. , 2002, Radiation protection dosimetry.
[19] Peter Green,et al. Markov chain Monte Carlo in Practice , 1996 .
[20] Harvey J Clewell,et al. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. , 2006, Regulatory toxicology and pharmacology : RTP.
[21] Harvey J Clewell,et al. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. , 2007, Regulatory toxicology and pharmacology : RTP.
[22] F. Jonsson. Physiologically based pharmacokinetic modeling in risk assessment : Development of Bayesian population methods , 2001 .
[23] Jason Bond,et al. Interactive Correspondence Analysis in a Dynamic Object-Oriented Environment , 1997 .
[24] P. Stolpman,et al. Environmental Protection Agency , 2020, The Grants Register 2022.
[25] F Y Bois,et al. Statistical issues in toxicokinetic modeling: a bayesian perspective. , 2000, Environmental health perspectives.
[26] Michael A. Gallo,et al. Reconstruction of short-term multi-route exposure to volatile organic compounds using physiologically based pharmacokinetic models , 1994 .
[27] C P Weisel,et al. Studies of Multiroute Exposure/Dose Reconstruction Using Physiologically Based Pharmacokinetic Models 1 , 1996, Toxicology and industrial health.
[28] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[29] M. Delp,et al. Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.